Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lord

Showing results (241-250 of 594) with videos related to

Pageof 60
Sort By:
Molecular Cell|March 4, 2008
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box moduleDavid Komander, Christopher J Lord, Hartmut Scheel, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 24, 2006
Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvementAhmad I Alomari, Victoria E Karian, David J Lord, et al.
BMJ Open|April 21, 2023
Global prevalence of hospital admissions for low back pain: a systematic review with meta-analysisAlla Melman, Harrison J Lord, Danielle Coombs, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2026
Regulated development of cannibalistic supergiant cells in the ciliate <i>Euplotes gigatrox</i>Ben T Larson, Daniele Giannotti, Mahara Mtawali, et al.
Chemistry of Materials : a Publication of the American Chemical Society|February 9, 2010
Bright, Red Single-Molecule Emitters: Synthesis and Properties of Environmentally Sensitive Dicyanomethylenedihydrofuran (DCDHF) Fluorophores with Bisaromatic ConjugationZhikuan Lu, Na Liu, Samuel J Lord, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2016
Safety of Osseointegrated Implants for Transfemoral Amputees: A Two-Center Prospective Cohort StudyMunjed Al Muderis, Aditya Khemka, Sarah J Lord, et al.
EMBO Molecular Medicine|August 31, 2012
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cellsIlirjana Bajrami, Asha Kigozi, Antoinette Van Weverwijk, et al.
Open Biology|July 27, 2022
Opinion: PARP inhibitors in cancer-what do we still need to know?Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt, et al.
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
The Bone & Joint Journal|July 2, 2016
The Osseointegration Group of Australia Accelerated Protocol (OGAAP-1) for two-stage osseointegrated reconstruction of amputated limbsM Al Muderis, K Tetsworth, A Khemka, et al.
Pageof 60

Showing results (241-250 of 594) with videos related to

Sort By:
Pageof 60
Molecular Cell|March 4, 2008
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box moduleDavid Komander, Christopher J Lord, Hartmut Scheel, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 24, 2006
Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvementAhmad I Alomari, Victoria E Karian, David J Lord, et al.
BMJ Open|April 21, 2023
Global prevalence of hospital admissions for low back pain: a systematic review with meta-analysisAlla Melman, Harrison J Lord, Danielle Coombs, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2026
Regulated development of cannibalistic supergiant cells in the ciliate <i>Euplotes gigatrox</i>Ben T Larson, Daniele Giannotti, Mahara Mtawali, et al.
Chemistry of Materials : a Publication of the American Chemical Society|February 9, 2010
Bright, Red Single-Molecule Emitters: Synthesis and Properties of Environmentally Sensitive Dicyanomethylenedihydrofuran (DCDHF) Fluorophores with Bisaromatic ConjugationZhikuan Lu, Na Liu, Samuel J Lord, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2016
Safety of Osseointegrated Implants for Transfemoral Amputees: A Two-Center Prospective Cohort StudyMunjed Al Muderis, Aditya Khemka, Sarah J Lord, et al.
EMBO Molecular Medicine|August 31, 2012
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cellsIlirjana Bajrami, Asha Kigozi, Antoinette Van Weverwijk, et al.
Open Biology|July 27, 2022
Opinion: PARP inhibitors in cancer-what do we still need to know?Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt, et al.
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
The Bone & Joint Journal|July 2, 2016
The Osseointegration Group of Australia Accelerated Protocol (OGAAP-1) for two-stage osseointegrated reconstruction of amputated limbsM Al Muderis, K Tetsworth, A Khemka, et al.
Pageof 60